Lupin Digital Health announced the launch of VITALYFE?, an AI-powered cardiometabolic wellness platform designed to help India's working professionals reclaim their heart health. Built on the foundation of LYFE ? India's first CDSCO-approved Class C software medical device (SaMD) for critical cardiac conditions ? VITALYFE? extends hospital-grade cardiac expertise to preventive wellness for its users.
?Cardiometabolic risks silently erode both health and productivity,? said Rajeev Sibal, President - India Region Formulations, Lupin. ?With VITALYFE, we are enabling insurers and employers to combine clinical expertise with AI-driven technology to deliver scalable, measurable wellness outcomes for millions of working Indians.?
Powered by Capital Market - Live News